FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007489871> ?p ?o ?g. }

• W2007489871 endingPage "217" @default.
• W2007489871 startingPage "210" @default.
• W2007489871 abstract "Neoadjuvant chemotherapy followed by surgery is a promising approach in locally advanced cervical carcinoma. The aim of this study was to evaluate the feasibility, technical aspects, and clinical results of surgery after induction chemotherapy in this patient population. Forty-one untreated cervical carcinoma patients staged as IB2 to IIIB received three 21-day courses of cisplatin 100mg/m2 on day 1 and gemcitabine 1000 mg/m2 on days 1 and 8 followed by surgery or concomitant chemoradiation. The response to chemotherapy, operability, surgical/pathological findings, disease-free period, and survival of the surgically treated patients were evaluated. All 41 patients were evaluated for toxicity and 40 were evaluated for response. The overall objective response rate was 95% (95% confidence interval 88%-100%), and was complete in three patients (7.5%) and partial in 35 (87.5%). Granulocytopenia grades 3/4 occurred in 13.8% and 3.4% of the courses, respectively, whereas nonhematological toxicity was mild. Twenty-three patients underwent type III radical hysterectomy. Mean duration of surgery was 3.8 h (range 2:30-5:20), median estimated blood loss was 670 ml and median hospital stay was 5.2 days. Intraoperative complications occurred in one case (venous injury). In all but one case the resection margins were negative. Four patients (17%) had positive nodes (one node each); six (26%) had complete pathologic response, three (13%) had microscopic; and 14 (60%) macroscopic residual disease. At 24 months of maximum follow-up (median 20), the disease-free and overall survival rates were 59% and 91%, respectively. Induction chemotherapy with cisplatin/gemcitabine produced a high response rate and did not increase the difficulty of surgery. Operating time, blood loss, intraoperative complications, and hospital stay were all within the range observed for type III hysterectomy in early stage patients. We therefore conclude that type III radical hysterectomy is feasible in locally advanced cervical cancer patients who respond to chemotherapy." @default.
• W2007489871 created "2016-06-24" @default.
• W2007489871 creator A5003330826 @default.
• W2007489871 creator A5049134620 @default.
• W2007489871 creator A5055089156 @default.
• W2007489871 creator A5055105004 @default.
• W2007489871 creator A5061536691 @default.
• W2007489871 creator A5070192692 @default.
• W2007489871 creator A5073251737 @default.
• W2007489871 creator A5074529046 @default.
• W2007489871 creator A5083576522 @default.
• W2007489871 date "2001-05-08" @default.
• W2007489871 modified "2023-10-18" @default.
• W2007489871 title "Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma" @default.
• W2007489871 cites W1935824237 @default.
• W2007489871 cites W1942577196 @default.
• W2007489871 cites W1953373541 @default.
• W2007489871 cites W1977126707 @default.
• W2007489871 cites W1983606775 @default.
• W2007489871 cites W1986231489 @default.
• W2007489871 cites W1997147545 @default.
• W2007489871 cites W2009891812 @default.
• W2007489871 cites W2024801263 @default.
• W2007489871 cites W2034194427 @default.
• W2007489871 cites W2039760394 @default.
• W2007489871 cites W2043945205 @default.
• W2007489871 cites W2056018298 @default.
• W2007489871 cites W2065386735 @default.
• W2007489871 cites W2089643986 @default.
• W2007489871 cites W2157719711 @default.
• W2007489871 cites W2159997815 @default.
• W2007489871 cites W2167805334 @default.
• W2007489871 cites W2263001779 @default.
• W2007489871 cites W2314753133 @default.
• W2007489871 cites W2324392028 @default.
• W2007489871 cites W2328935341 @default.
• W2007489871 cites W4250894784 @default.
• W2007489871 cites W4293241248 @default.
• W2007489871 doi "https://doi.org/10.1046/j.1525-1438.2001.01012.x" @default.
• W2007489871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11437927" @default.
• W2007489871 hasPublicationYear "2001" @default.
• W2007489871 type Work @default.
• W2007489871 sameAs 2007489871 @default.
• W2007489871 citedByCount "21" @default.
• W2007489871 countsByYear W20074898712020 @default.
• W2007489871 crossrefType "journal-article" @default.
• W2007489871 hasAuthorship W2007489871A5003330826 @default.
• W2007489871 hasAuthorship W2007489871A5049134620 @default.
• W2007489871 hasAuthorship W2007489871A5055089156 @default.
• W2007489871 hasAuthorship W2007489871A5055105004 @default.
• W2007489871 hasAuthorship W2007489871A5061536691 @default.
• W2007489871 hasAuthorship W2007489871A5070192692 @default.
• W2007489871 hasAuthorship W2007489871A5073251737 @default.
• W2007489871 hasAuthorship W2007489871A5074529046 @default.
• W2007489871 hasAuthorship W2007489871A5083576522 @default.
• W2007489871 hasConcept C121608353 @default.
• W2007489871 hasConcept C126322002 @default.
• W2007489871 hasConcept C141071460 @default.
• W2007489871 hasConcept C146357865 @default.
• W2007489871 hasConcept C151730666 @default.
• W2007489871 hasConcept C2776611710 @default.
• W2007489871 hasConcept C2776694085 @default.
• W2007489871 hasConcept C2776874909 @default.
• W2007489871 hasConcept C2777546739 @default.
• W2007489871 hasConcept C2778220009 @default.
• W2007489871 hasConcept C2779494336 @default.
• W2007489871 hasConcept C2780258809 @default.
• W2007489871 hasConcept C2993195994 @default.
• W2007489871 hasConcept C71924100 @default.
• W2007489871 hasConcept C86803240 @default.
• W2007489871 hasConceptScore W2007489871C121608353 @default.
• W2007489871 hasConceptScore W2007489871C126322002 @default.
• W2007489871 hasConceptScore W2007489871C141071460 @default.
• W2007489871 hasConceptScore W2007489871C146357865 @default.
• W2007489871 hasConceptScore W2007489871C151730666 @default.
• W2007489871 hasConceptScore W2007489871C2776611710 @default.
• W2007489871 hasConceptScore W2007489871C2776694085 @default.
• W2007489871 hasConceptScore W2007489871C2776874909 @default.
• W2007489871 hasConceptScore W2007489871C2777546739 @default.
• W2007489871 hasConceptScore W2007489871C2778220009 @default.
• W2007489871 hasConceptScore W2007489871C2779494336 @default.
• W2007489871 hasConceptScore W2007489871C2780258809 @default.
• W2007489871 hasConceptScore W2007489871C2993195994 @default.
• W2007489871 hasConceptScore W2007489871C71924100 @default.
• W2007489871 hasConceptScore W2007489871C86803240 @default.
• W2007489871 hasIssue "3" @default.
• W2007489871 hasLocation W20074898711 @default.
• W2007489871 hasLocation W20074898712 @default.
• W2007489871 hasOpenAccess W2007489871 @default.
• W2007489871 hasPrimaryLocation W20074898711 @default.
• W2007489871 hasRelatedWork W2023843410 @default.
• W2007489871 hasRelatedWork W2349390505 @default.
• W2007489871 hasRelatedWork W2351245677 @default.
• W2007489871 hasRelatedWork W2363109721 @default.
• W2007489871 hasRelatedWork W2370148199 @default.
• W2007489871 hasRelatedWork W2378058187 @default.
• W2007489871 hasRelatedWork W2382497227 @default.
• W2007489871 hasRelatedWork W2956054768 @default.

• next